Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers

Muñoz García, Delicia; Dapena Bolaño, Dolores; Pego Reigosa, Robustiano
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/1864
PMID: 23845043
ISSN: 1471-2377
Full record
Services
Services
RISMendeleyLinksolver
Date issued
2013
Journal title
BMC Neurology
Type of content
Artigo